Literature DB >> 30594640

Sublichenin, a new subtilin-like lantibiotics of probiotic bacterium Bacillus licheniformis MCC 2512T with antibacterial activity.

Prakash M Halami1.   

Abstract

Probiotic bacteria with antibacterial activity is of desirable trait since they can check the growth of pathogenic bacteria besides exhibiting health benefits to host. Aim of this study was to characterize Bacillus licheniformis MCC 2512T (MCC 2512), a potential probiotic culture for its ability to produce subtilin-like antibiotics. The anti-microbial compound produced by MCC 2512 was identified and characterized using subtilin-specific cell reporter, Bacillus subtilis 168:BS2 (BS2). Induction of β-gal by the test culture suggested the ability of B. licheniformis to produce subtilin-like lantibiotic. Subsequently, DNA sequencing of major lanS-operon was carried out, wherein sequencing results showed that lan cluster of MCC 2512 resembles entianin (etn) type. Upon lan-S disruption, the bacterial culture lost antimicrobial activity as well as ability to induce β-gal with BS2 reporter. High amount of succinylated form of antibiotics produced by wild type and un-succinylated form by engineered strain of B. subtilis 15029p clearly indicates that MCC 2512 is indeed an inter-specific subtilin-like (named as sublichenin) lantibiotic producer. Partially concentrated sublichenin preparation exhibited strong antibacterial activity against food-borne pathogens and antibiotic resistant (AR) lactic acid bacteria (LAB) with a minimum inhibitory concentration in the range of 6-10 and 0.5-1.5 μg/ml, respectively. Production of lantibiotic, sublichenin by a probiotic bacterium of B. licheniformis MCC 2512T and its antibacterial activity against food associated AR LAB is a new information reported in this study.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-Bacterial activity; Auto-induction; Bacillus licheniformis; Lan operon; Subtilin-like lantibiotics; Succinylation

Mesh:

Substances:

Year:  2018        PMID: 30594640     DOI: 10.1016/j.micpath.2018.12.044

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  3 in total

Review 1.  Potential role of gut microbiota in patients with COVID-19, its relationship with lung axis, central nervous system (CNS) axis, and improvement with probiotic therapy.

Authors:  Nazanin Alibeik; Elham Pishgar; Ramin Bozorgmehr; Farshad Aghaaliakbari; Neda Rahimian
Journal:  Iran J Microbiol       Date:  2022-02

2.  Distribution and Diversity of Nisin Producing LAB in Fermented Food.

Authors:  Basista Rabina Sharma; Dharana Jayant; Kumari Rajshee; Yashika Singh; Prakash M Halami
Journal:  Curr Microbiol       Date:  2021-07-13       Impact factor: 2.188

Review 3.  Novel pathways in bacteriocin synthesis by lactic acid bacteria with special reference to ethnic fermented foods.

Authors:  Basista Rabina Sharma; Prakash M Halami; Jyoti Prakash Tamang
Journal:  Food Sci Biotechnol       Date:  2021-10-26       Impact factor: 2.391

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.